Boston Scientific Corporation (NYSE:BSX) spent the opening hour sharply lower but recovered in the latter hours to end the session with a meager loss of only 1.28%. The volume at 19 million was double the daily average of 9 million only but even then it was not very significant, especially on a results day.
The adjusted earnings per share came at $0.14, an improvement of 7.6% compared to the year-ago adjusted number. Considering amortized expense adjustments, the adjusted EPS turns out to be $0.21, in line with the consensus estimates. This unimpressive result has forced the company to lower its full year 2015 revenue guidance to the range of $7.225-$7.375 from the earlier $7.300-$7.500.
Technically, the stock has been in a huge bull market for more than two years now. In the period of 2004-2008, long before the bear attacked the broader market, this stock began its decline to $5 levels from the $45 levels. That decline was followed by a large sideways phase in 2009-2012 and then came the real rally. The stock has already appreciated over 3 times in as many years and looks ready to rise some more.
The stock broke out of the sideways range in May 2013 and rallied very fast to $14 from $5. The next correction ended in the vicinity of $11 levels. A projection of equality with the first rally from the $11 levels gives us the target of about $20, which also coincides with the $19.50-$20.00 target coming from Elliott Wave Theory application.
The short term chart attached clearly shows the channel contain the price action in the last few months. The correction yesterday tested the channel support, showed near perfect equality with the previous significant correction and lastly, formed a Bullish Hammer candle waiting for confirmation. All these things increase the probability of seeing a new 52-week high soon enough in the vicinity of $19.50-$20.00.
